Unverified50% confidenceFactExact time
The European LeukemiaNet (ELN) 2022 guidelines recommend MRD assessment at key treatment milestones.
1
Sources
50%
Confidence
Long-term
Relevance
9/6/2026
First Seen
Sources
Related Entities
Related Claims
Cite This Claim
Stable URI
https://kongchang.com/claim/864687API
curl https://kongchang.com/api/v1/knowledge/claims/864687MCP
get_claim(id=864687)